Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Xbrane Biopharma AB

Closing information (x1000 DKK)

Closing information 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Turnover 38,502 Less Arrow 0 Equal arrow 0
Financial expenses 1,534 More Arrow 1,922 Less Arrow 569
Earnings before taxes -112,606 Less Arrow -133,229 Less Arrow -167,522
EBITDA -106,099 Less Arrow -122,424
Total assets 461,425 More Arrow 500,577 Less Arrow 343,723
Current assets 343,154 More Arrow 407,927 Less Arrow 277,551
Current liabilities 158,083 More Arrow 159,727 Less Arrow 140,074
Equity capital 283,924 More Arrow 313,932 Less Arrow 191,003
- share capital 4,120 Less Arrow 4,082 Less Arrow 2,561
Employees (average) 68 Less Arrow 50 Less Arrow 39

Financial ratios

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Solvency 61.5% More Arrow 62.7% Less Arrow 55.6%
Turnover per employee 566 Less Arrow 0 Equal arrow 0
Profit as a percentage of turnover -292.5%
Return on assets (ROA) -24.1% Less Arrow -26.2% Less Arrow -48.6%
Current ratio 217.1% More Arrow 255.4% Less Arrow 198.1%
Return on equity (ROE) -39.7% Less Arrow -42.4% Less Arrow -87.7%
Change turnover 38,502 Less Arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 18 Less Arrow 11 Less Arrow 3
Chg. No. of employees % 36% Less Arrow 28% Less Arrow 8%

Total value of public sale

Fiscal year 2022/12 (consolidated) 2021/12 (consolidated) 2020/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.